Results 31 to 40 of about 10,639 (217)

Elevated circulating soluble interleukin-2 receptor in patients with chronic liver diseases is associated with non-classical monocytes

open access: yesBMC Gastroenterology, 2012
Background The soluble interleukin-2 receptor (sIL-2R, sIL2R, sTAC, sCD25) is a reliable biomarker for disease activity in inflammatory disorders such as sarcoidosis.
Seidler Sebastian   +4 more
doaj   +1 more source

Association of high serum soluble interleukin 2 receptor levels with risk of adverse events in cardiac sarcoidosis

open access: yesESC Heart Failure, 2021
Aims Although soluble interleukin 2 receptor (sIL‐2R) is a potentially useful biomarker in the diagnosis and evaluation of disease severity in patients with sarcoidosis, its prognostic implication in patients with cardiac sarcoidosis (CS) is unclear.
Yuta Kobayashi   +13 more
doaj   +1 more source

A case of transverse colon cancer with remarkable extramural invasion to stomach and jejunum [PDF]

open access: yes, 2010
A 77-year-old woman was admitted to our hospital due to abdominal pain and body weight loss. A palpable mass the size of an infant's head was tender on palpation and identified as an epigastric lesion.
Hamano, Ryosuke   +9 more
core   +1 more source

Soluble interleukin 2 receptor is risk for sarcopenia in Men with high fracture risk

open access: yesJournal of Orthopaedic Translation, 2023
Background & aims: Sarcopenia is an age-related disease that increases the risk of falls and fractures in older adults. However, there is no blood biochemical marker to help to predict or diagnose sarcopenia in clinical practice.
Jiaying Ge   +11 more
doaj   +1 more source

Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways [PDF]

open access: yes, 2012
It is of considerable translational importance whether depression is a form or a consequence of sickness behavior. Sickness behavior is a behavioral complex induced by infections and immune trauma and mediated by pro-inflammatory cytokines.
A Bosutti   +189 more
core   +2 more sources

Elevation of soluble interleukin-2 receptor levels in nasal allergy

open access: yesMediators of Inflammation, 1995
To investigate soluble IL-2 receptor (sIL-2R) levels in nasal allergy, the sera and nasal secretions from patients with nasal allergy and from healthy subjects were subjected to a double-epitope enzyme-linked immunosorbent assay. Significant elevation of
K. Hisamatsu   +5 more
doaj   +1 more source

Soluble IL-2R Levels at Baseline Predict the Development of Severe Respiratory Failure and Mortality in COVID-19 Patients

open access: yesViruses, 2022
Risk stratification of coronavirus disease-19 (COVID-19) patients by simple markers is critical to guide treatment. We studied the predictive value of soluble interleukin-2 receptor (sIL-2R) for the early identification of patients at risk of developing ...
Nikolaos K. Gatselis   +15 more
doaj   +1 more source

Coagulation, fibrinolysis, and cell activation in patients and shed mediastinal blood during coronary artery bypass grafting with a new heparin-coated surface [PDF]

open access: yes, 2002
Objectives: Heparin coating of the cardiopulmonary bypass circuit is shown to improve the biocompatibility of the surface. We have studied a new heparin surface, the Corline Heparin Surface, applied to a complete set of an extracorporeal device used ...
Johnell, Matilda   +5 more
core   +1 more source

Soluble Interleukin-2 Receptor Predicts Treatment Outcome in Patients With Autoimmune Tubulointerstitial Nephritis. A Preliminary Study

open access: yesFrontiers in Medicine, 2022
BackgroundAutoimmune tubulointerstitial nephritis (TIN) is characterized by immune-mediated tubular injury and requires immunosuppressive therapy. However, diagnosing TIN and assessing therapeutic response are challenging for clinicians due to the lack ...
Satoka Shiratori-Aso   +17 more
doaj   +1 more source

Soluble interleukin-2 receptor (sIL-2R) is a marker of disease activity in psoriasis: a comparison of sIL-2R, sCD27, sCD4, sCD8 and sICAM-1.

open access: yesActa Dermato-Venereologica, 1996
Psoriasis is a T-cell-mediated inflammatory skin disease which can be treated successfully with immunosuppressive drugs. Our purpose was to evaluate disease activity of psoriasis and the effect of immunosuppressive treatment by monitoring the soluble T-cell products sIL-2R, sCD27, sCD4, sCD8 and sICAM-1.
de Rie, M. A.   +5 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy